Medicines and Healthcare products Regulatory Agency: Finance

Department of Health and Social Care written question – answered on 7th December 2018.

Alert me about debates like this

Photo of Ben Bradshaw Ben Bradshaw Labour, Exeter

To ask the Secretary of State for Health and Social Care, how much funding for contingency planning for the UK leaving the EU without a deal will be made available to the Medicines and Healthcare products Regulatory Agency for the development of new processes or systems including software.

Photo of Jackie Doyle-Price Jackie Doyle-Price The Parliamentary Under-Secretary for Health and Social Care

The Department continues to work with partners across Government, industry and its arm’s-length bodies (ALBs), including the Medicines and Healthcare products Regulatory Agency (MHRA), to ensure that required systems and processes, including software, will be available on Exit Day. Support is being provided including European Union exit funding for contingency preparations where it is necessary and the Department is engaging with its ALBs including MHRA to ensure their needs are met.

The Autumn Budget 2018 confirmed an additional £500 million of cross-Government EU exit funding for 2019/20, meaning the Government will have invested over £4 billion in preparing for EU exit since 2016.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.